Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Emcure Pharmaceuticals Ltd.
NSE: EMCURE
|
BSE: 544210
|
ISIN: INE168P01015
|
Industry: Pharmaceuticals
Rising Revenue
|
Mid-range Performer
1515.7000
33.40
(
2.25
%)
NSE
Feb 06, 2026
15:31 PM
Near 52W High of ₹1585.60
Volume:
94,187
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Emcure Pharmaceuticals Ltd.
02 Jul 2024
Rising Revenue
1515.70
2.25%
IPO Note Emcure Pharmaceuticals Ltd.
IPO Note:
Emcure Pharmaceuticals Ltd.
by
Ashika Research
Ashika Research
BOB Capital Markets Ltd. increased Buy price target of Emcure Pharmaceuticals Ltd. to 1787.0 on 05 Feb, 2026.
More from Emcure Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - February 6, 2026
The Baseline |
06 Feb 2026, 04:20PM
Market closes higher as RBI raises FY26 GDP growth forecast to 7.4%
Trendlyne Marketwatch |
06 Feb 2026, 04:08PM
Buybacks after the tax reset: What has changed?
The Baseline |
05 Feb 2026, 03:51PM